Cytotoxicity and apoptosis by survivin small interfering RNA in bladder cancer cells

BJU International

Volumn 106, Issue 11, 2010, Pages 1812-1816

  Ku, Ja H ^a   Seo, Soo Y ^a   Kwak, Cheol ^a   Kim, Hyeon H ^a  

^a Seoul National University Hospital   (South Korea)

Author keywords

bladder; bladder neoplasm; small interfering RNA; survivin

Indexed keywords

CASPASE 3; SMALL INTERFERING RNA; SURVIVIN;

APOPTOSIS; ARTICLE; BLADDER CANCER; CANCER CELL; CELL CYCLE ARREST; CELL DENSITY; CELL GROWTH; CELL STRAIN T24; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; CASPASE 3; CELL LINE, TUMOR; DOWN-REGULATION; GENE THERAPY; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; TRANSFECTION; URINARY BLADDER NEOPLASMS;

EID: 78649246962     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2010.09259.x     Document Type: Article

References (25)

1. Ambrosini G, Adida C, Altieri DC,. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 1997; 3: 917 - 21
2. Rodel F, Hoffmann J, Distel L, et al. Survivin as a radioresistance factor, and prognostic and therapeutic target for radiotherapy in rectal cancer. Cancer Res 2005; 65: 4881 - 7
3. Atlasi Y, Mowla SJ, Ziaee SA,. Differential expression of survivin and its splice variants, survivin-DeltaEx3 and survivin-2B, in bladder cancer. Cancer Detect Prev 2009; 32: 308 - 13
4. Shariat SF, Casella R, Khoddami SM, et al. Urine detection of survivin is a sensitive marker for the noninvasive diagnosis of bladder cancer. J Urol 2004; 171: 626 - 30
5. Ku JH, Kwak C, Lee HS, Park HK, Lee E, Lee SE,. Expression of survivin, a novel inhibitor if apoptosis, in superficial transitional cell carcinoma of the bladder. J Urol 2004; 171: 631 - 5
6. Gonzalez S, Aubert S, Kerfraon O, et al. Prognostic value of combined p53 and survivin in pT1G3 urothelial carcinoma of the bladder. Am J Clin Pathol 2008; 129: 232 - 7
7. Weiss C, Von Romer F, Capalbo G, et al. Survivin expression as a predictive marker for local control in patients with high-risk T1 bladder cancer treated with transurethral resection and radiochemotherapy. Int J Radiat Oncol Biol Phys 2009; 74: 1455 - 60
8. Shariat SF, Ashfaq R, Karakiewicz PI, Saeedi O, Sagalowsky AI, Lotan Y,. Survivin expression is associated with bladder cancer presence, stage, progression, and mortality. Cancer 2007; 109: 1106 - 13
9. Altieri DC,. Survivin, versatile modulation of cell division and apoptosis in cancer. Oncogene 2003; 22: 8581 - 9
10. Altieri DC,. The molecular basis and potential role of survivin in cancer diagnosis and therapy. Trends Mol Med 2001; 7: 542 - 7
11. Suzuki A, Ito T, Kawano H, et al. Survivin initiates procaspase3/p21 complex formation as a result of interaction with Cdk4 to resist Fas-mediated cell death. Oncogene 2000; 19: 1346 - 53
12. Shin S, Sung BJ, Cho YS, et al. An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7. Biochem 2001; 40: 1117 - 23
13. Altieri DC,. Validating survivin as a cancer therapeutic target. Nat Rev Cancer 2003; 3: 46 - 54
14. Zaffaroni N, Pennati M, Daidone MG,. Survivin as a target for new anticancer interventions. J Cell Mol Med 2005; 9: 360 - 72
15. Ambrosini G, Adida C, Sirugo G, Altieri DC,. Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting. J Biol Chem 1998; 273: 11172 - 82
16. Grossman D, McNiff JM, Li F, Altieri DC,. Expression of the apoptosis inhibitor, survivin, in nonmelanoma skin cancer and gene targeting in a keratinocyte cell line. Lab Invest 1999; 79: 1121 - 6
17. Olie RA, Simoes-Wust AP, Baumann B, et al. A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitized lung cancer cells to chemotherapy. Cancer Res 2000; 60: 2805 - 9
18. Konnikova L, Kotecki M, Kruger MM, Cochran BH,. Knockdown of STAT3 expression by RNAi induces apoptosis in astrocytoma cells. BMC Cancer 2003; 3: 23
19. Tuschl T, Borkhardt A,. Small interfering RNAs: a revolutionary tool for the analysis of gene function and gene therapy. Mol Interv 2002; 2: 158 - 67
20. Cheng SQ, Wang WL, Yan W, Li QL, Wang L, Wang WY,. Knockdown of survivin gene expression by RNAi induces apoptosis in human hepatocellular carcinoma cell line SMMC-7721. World J Gastroenterol 2005; 11: 756 - 9
21. Yang H, Fu JH, Hu Y, et al. Influence of siRNA targeting survivin on chemosensitivity of H460/cDDP lung cancer cells. J Int Med Res 2008; 36: 734 - 47
22. Ning S, Fuessel S, Kotzsch M, et al. siRNA-mediated down-regulation of survivin inhibits bladder cancer cell growth. Int J Oncol 2004; 25: 1065 - 71
23. Fuessel S, Herrmann J, Ning S, et al. Chemosensitization of bladder cancer cells by survivin-directed antisense oligodeoxynucleotides and siRNA. Cancer Lett 2006; 232: 243 - 54
24. Takizawa BT, Uchio EM, Cohen JJ, Wheeler MA, Weiss RM,. Downregulation of survivin is associated with reductions in TNF receptors' mRNA and protein and alterations in nuclear factor kappa B signaling in urothelial cancer cells. Cancer Invest 2007; 25: 678 - 84
25. Tolcher AW, Mita A, Lewis LD, et al. Phase I and pharmacokinetic study of YM155, a small-molecule inhibitor of survivin. J Clin Oncol 2008; 26: 5198 - 203